44 research outputs found
La rehabilitación del edificio neoclásico "El Gran Tinglado y Maestranzas" en el Arsenal de Ferrol (1765-1989)
Extracellular vesicles from Listeria monocytogenes-infected dendritic cells alert the innate immune response.
Communication through cell-cell contacts and extracellular vesicles (EVs) enables immune cells to coordinate their responses against diverse types of pathogens. The function exerted by EVs in this context depends on the proteins and nucleic acids loaded into EVs, which elicit specific responses involved in the resolution of infection. Several mechanisms control protein and nucleic acid loading into EVs; in this regard, acetylation has been described as a mechanism of cellular retention during protein sorting to exosomes. HDAC6 is a deacetylase involved in the control of cytoskeleton trafficking, organelle polarity and cell migration, defense against Listeria monocytogenes (Lm) infection and other immune related functions. Here, we show that the protein content of dendritic cells (DCs) and their secreted EVs (DEVs) vary during Lm infection, is enriched in proteins related to antiviral functions compared to non-infected cells and depends on HDAC6 expression. Analyses of the post-translational modifications revealed an alteration of the acetylation and ubiquitination profiles upon Lm infection both in DC lysates and DEVs. Functionally, EVs derived from infected DCs upregulate anti-pathogenic genes (e.g. inflammatory cytokines) in recipient immature DCs, which translated into protection from subsequent infection with vaccinia virus. Interestingly, absence of Listeriolysin O in Lm prevents DEVs from inducing this anti-viral state. In summary, these data underscore a new mechanism of communication between bacteria-infected DC during infection as they alert neighboring, uninfected DCs to promote antiviral responses.This study was supported by grant PDI-2020-120412RB-I00,
PDC2021-121797-I00, BIO2015-67580-P and PGC2018-097019-BI00 from the Spanish Ministry of Economy and Competitiveness
(MINECO), grant S2017/BMD-3671-INFLAMUNE-CM from the
Comunidad de Madrid, a grant from the Ramón Areces Foundation
“Ciencias de la Vida y la Salud” (XIX Concurso-2018), “la Caixa”
Banking Foundation (grants HR17-00016 and HR17-00247),
BIOIMID (PIE13/041) and PRB3 (IPT17/0019 - ISCIII-SGEFI/
ERDF, ProteoRed) from Instituto de Salud Carlos III, CIBER
Cardiovascular (CB16/11/00272), and Fondo de Investigación
Sanitaria del Instituto de Salud Carlos III and co-funding by Fondo
Europeo de Desarrollo Regional FEDER). IF-D is supported by a
Fellowship from the Spanish Ministry of Science, Innovation, and
Universities (FPU15/02539). DC-F is supported by a Fellowship
from “la Caixa” Foundation (LCF/BQ/DR19/11740010). The CNIC
is supported by the Instituto de Salud Carlos III (ISCIII), the
Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC
Foundation, and is a Severo Ochoa Center of Excellence (CEX2020-
001041-S). Funding agencies did not intervene in the design of the
studies, with no copyright over the study.S
The impact of type 2 immunity and allergic diseases in atherosclerosis.
Allergic diseases are allergen-induced immunological disorders characterized by the development of type 2 immunity and IgE responses. The prevalence of allergic diseases has been on the rise alike cardiovascular disease (CVD), which affects arteries of different organs such as the heart, the kidney and the brain. The underlying cause of CVD is often atherosclerosis, a disease distinguished by endothelial dysfunction, fibrofatty material accumulation in the intima of the artery wall, smooth muscle cell proliferation, and Th1 inflammation. The opposed T-cell identity of allergy and atherosclerosis implies an atheroprotective role for Th2 cells by counteracting Th1 responses. Yet, the clinical association between allergic disease and CVD argues against it. Within, we review different phases of allergic pathology, basic immunological mechanisms of atherosclerosis and the clinical association between allergic diseases (particularly asthma, atopic dermatitis, allergic rhinitis and food allergy) and CVD. Then, we discuss putative atherogenic mechanisms of type 2 immunity and allergic inflammation including acute allergic reactions (IgE, IgG1, mast cells, macrophages and allergic mediators such as vasoactive components, growth factors and those derived from the complement, contact and coagulation systems) and late phase inflammation (Th2 cells, eosinophils, type 2 innate-like lymphoid cells, alarmins, IL-4, IL-5, IL-9, IL-13 and IL-17).Severo Ochoa Center of Excellence,
Grant/Award Number: CEX2020-001041-
S;
Pro CNIC Foundation;
Ministerio de Ciencia e Innovación;
Ministry of Science and Innovation, Grant/
Award Number: PID2019-110369RB-
I00;
European Commission, Grant/Award
Number: ERC-CoG
819775 and H2020-HEALTH
945118; Spanish Ministry of
Universities; Ayudas Margarita Salas
para la Formación de Jóvenes Doctores—Universidad
Autónoma de Madrid, Grant/
Award Number: CA1/RSUE/2021–00577;
Formación de Profesorado Universitario,
Grant/Award Number: FPU16/03953;
Sociedad Española de Alergología e
Inmunología Clínica (SEAIC), Grant/
Award Number: BECA20A9; New
Frontiers in Research Fund, Grant/
Award Number: NFRFE-2019-
00083;
The Nutricia Research Foundation,
Grant/Award Number: NRF-2021-
13;
Instituto de Salud Carlos III, Grant/Award
Number: PI21/00158, PI21/01126,
CP20/00043, PI18/01467, PI19/00044,
RD16/0006/0015 and RD21/0002/0008;
Severo Ochoa Program, Grant/Award
Number: AEI/SEV-2017-
0712S
The impact of type 2 immunity and allergic diseases in atherosclerosis.
Allergic diseases are allergen-induced immunological disorders characterized by the development of type 2 immunity and IgE responses. The prevalence of allergic diseases has been on the rise alike cardiovascular disease (CVD), which affects arteries of different organs such as the heart, the kidney and the brain. The underlying cause of CVD is often atherosclerosis, a disease distinguished by endothelial dysfunction, fibrofatty material accumulation in the intima of the artery wall, smooth muscle cell proliferation, and Th1 inflammation. The opposed T-cell identity of allergy and atherosclerosis implies an atheroprotective role for Th2 cells by counteracting Th1 responses. Yet, the clinical association between allergic disease and CVD argues against it. Within, we review different phases of allergic pathology, basic immunological mechanisms of atherosclerosis and the clinical association between allergic diseases (particularly asthma, atopic dermatitis, allergic rhinitis and food allergy) and CVD. Then, we discuss putative atherogenic mechanisms of type 2 immunity and allergic inflammation including acute allergic reactions (IgE, IgG1, mast cells, macrophages and allergic mediators such as vasoactive components, growth factors and those derived from the complement, contact and coagulation systems) and late phase inflammation (Th2 cells, eosinophils, type 2 innate-like lymphoid cells, alarmins, IL-4, IL-5, IL-9, IL-13 and IL-17).N
DataSheet_1_Extracellular vesicles from Listeria monocytogenes-infected dendritic cells alert the innate immune response.pdf [Dataset]
Supplementary Figure 1. Isolated EVs present typical size and topology.
Supplementary Figure 2. Protein profiling from total cell lysates and their derived EVs from WT and KO-HDAC6 BMDCs.
Supplementary Figure 3. Enrichment in acetylated and ubiquitinated DC proteins upon Lm infection.
Supplementary Figure 4. Ubiquitination in K-48 and K-63 state in T lymphoblast total cell lysates and their derived EVs.
Supplementary Figure 5. Pore filtration methods restrain Lm and do not induce strong antipathogenic responses.
Supplementary Figure 6. IFN-β is detected following Lm infection.
Table S1. List of antibodies used for Western-blot and Flow Cytometry and the used dilution.
Table S2. List of primers, with their corresponding sequence, used for qPCR.
Table S3: Protein quantification in total cell lysates
Table S4: IPA analysis of total cell lysates: canonical pathways and diseases and functions category
Table S5: Protein quantification in EVs
Table S6: IPA analysis of EVs: diseases and functions category
Table S7: Ubiquitinated and acetylated peptides in total cell lysates and EVs
Table S8: Enrichment analysis of ubiquitinated and acetylated proteinsPeer reviewe